Smith & Nephew Share Discussion Threads

[pugugly] 01/10/2021 09:15

Covid uncertainty strikes again-
New low for year.

How much more damage PLUS of course the pending arrival of the fly season will be infliced here.

Guesses as to eventual low?

[essentialinvestor] 16/9/2021 11:32

Closed my trade for a few shekels, luck to holders.

[marcela9] 16/9/2021 10:52

oversold imho

[smcni1968] 15/9/2021 23:58

80% discounts in China, make it up in volume?

[ianood] 15/9/2021 16:50

Its in the UK, that's the problem!

[essentialinvestor] 15/9/2021 13:19

Stryker is not showing share price weakness so company specific would think.

[essentialinvestor] 14/9/2021 15:12

Had a small amount.

[pugugly] 14/9/2021 11:52

OK Covid protective measures winding down but infections up though looking as though starting to go down but deaths starting to increase -However with restrictions coming off and winter coming very likley (imo)to be an acceration to the upside of both cases hospitalisations and deaths and therefore a decline in elective surgery BAD for SN.


Use above link if you wish to double check trends -

[luzley] 14/9/2021 10:28

A little good news here would be more than welcome given the positive interims. Surely the Company has a fair indication of upswing now as Covid measures wind down. I think it would be prudent to issue an interim t/u in view of the continued share price erosion if only to stop the rot.

[suetballs] 10/9/2021 11:26

I'll take £18 now please.
Suet

[philanderer] 10/9/2021 11:02

BARCLAYS CUTS SMITH & NEPHEW PRICE TARGET TO 1,800 (1,825) PENCE - 'OVERWEIGHT'

[essentialinvestor] 24/8/2021 19:32

SP has bounced several times from the approx 13.75 type area.
Some type of support around there?, not holding atm.

[essentialinvestor] 24/8/2021 18:58

Today's RNS details shares issued partly in lieu of annual fees.


If you read yesterday's RNS, it's yet another director sale.

[csalvage] 24/8/2021 18:47

What's going on with this share director buys big price goes down.

[luzley] 16/8/2021 09:24

I expect we will get increasingly positive updates going forward as pent-up demand escalates and facilities reopen to clear backlogs. American healthcare consumers are not the most patient in the world.

[luzley] 16/8/2021 09:23

Affluent areas of US are facing much better - that's where most joint surgery is focused.

[suetballs] 16/8/2021 08:25

Ok so no quick profits - but long term I am optimistic.
Suet

[spoole5] 16/8/2021 08:16

Thing is most of their business is in the us where things are getting worse

[chard1980] 13/8/2021 22:19

Looking to invest here, this seems like a great company with bags of potential for a Covid recovery play. Watching closely.

[essentialinvestor] 12/8/2021 14:49

H2 guidance is predicated on normalisation of the COVID pandemic in their
major markets. Now currently we have the COVID situation in the US rapidly deteriorating-
hopefully that may peak within the next few weeks.


May be that is discounted at the current share price level, or someone else will see longer
term value and make an offer for the Company.


Ian, interesting re the epidural, these days they are far more cautious using GA.
Back in the day you were often put under general for even minor surgery.

[basildublin] 12/8/2021 14:39

Keyno, you’re right.
I got fed up waiting for someone to
make some enlightened comment that would put some life into this board, hopefully I’ve done that.
Now make some comment on what I said about
+37% to +49% that’s constructive !

[keyno] 12/8/2021 13:23

Basil has only been on ADVFN since yesterday.

[its the oxman] 12/8/2021 11:49

Bought a few today. Gotta b cheap.

[basildublin] 12/8/2021 10:49

Ian, when S&N say the numbers are the
correct interpretation of the guidance
it gives a certain validity to the figures.